Semi-Annual Consolidated Statement Of Cash Flows

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7731850

Concept 2017-04-01 to
2017-09-30
As at
2017-09-30
As at
2017-03-31
As at
2016-09-30
2016-04-01 to
2016-09-30
As at
2016-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
15,481,000,000 JPY
16,173,000,000 JPY
Depreciation
1,043,000,000 JPY
903,000,000 JPY
Interest and dividend income
-174,000,000 JPY
-155,000,000 JPY
Interest expenses
8,000,000 JPY
11,000,000 JPY
Increase (decrease) in retirement benefit liability
-1,000,000 JPY
-207,000,000 JPY
Decrease (increase) in trade receivables
-7,725,000,000 JPY
-351,000,000 JPY
Decrease (increase) in inventories
-566,000,000 JPY
-896,000,000 JPY
Increase (decrease) in trade payables
3,817,000,000 JPY
159,000,000 JPY
Other, net
1,833,000,000 JPY
-1,882,000,000 JPY
Subtotal
13,751,000,000 JPY
13,800,000,000 JPY
Interest and dividends received
174,000,000 JPY
155,000,000 JPY
Interest paid
-8,000,000 JPY
-11,000,000 JPY
Income taxes paid
-2,831,000,000 JPY
-8,245,000,000 JPY
Net cash provided by (used in) operating activities
11,086,000,000 JPY
5,699,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-497,000,000 JPY
-1,247,000,000 JPY
Purchase of investment securities
-1,000,000 JPY
-751,000,000 JPY
Other, net
-214,000,000 JPY
-112,000,000 JPY
Net cash provided by (used in) investing activities
-822,000,000 JPY
-2,151,000,000 JPY
Cash flows from financing activities
Dividends paid
-3,063,000,000 JPY
-3,223,000,000 JPY
Net cash provided by (used in) financing activities
-6,500,000,000 JPY
-6,729,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
JPY
JPY
Net increase (decrease) in cash and cash equivalents
3,763,000,000 JPY
-3,182,000,000 JPY
Cash and cash equivalents
47,530,000,000 JPY
43,767,000,000 JPY
38,562,000,000 JPY
41,744,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.